Literature DB >> 27483851

Enhanced Cytotoxicity of Biomolecules Loaded Metallic Silver Nanoparticles Against Human Liver (HepG2) and Prostate (PC3) Cancer Cell Lines.

Govindaraj Prasannaraj, Shivendra Vikram Sahi, Samandham Ravikumar, Perumal Venkatachalam.   

Abstract

Green nanoparticle synthesis was achieved using environmentally acceptable plant extracts reducing and capping agents. The present study was based on assessments to the anticancer activities to determine the effect of synthesized silver nanoparticles (AgNPs) from three medicinal plants on human liver (HepG2) and prostate (PC3) cancer cell lines. The synthesis of AgNPs using Plumbago zeylanica (Pz), Semecarpus anacardium (Sa) and Terminalia arjuna (Ta) plant extracts in the reaction mixture was monitored by UV-visible spectroscopy. FTIR results clearly illustrated that the plant extracts containing prominent peaks of functional groups and biomolecules viz., tannins, phenols, flavonoids and triterpenoids those act as capping agents and involved in the stabilization of the synthesised silver nanoparticles. Synthesized AgNPs were spherical and cuboid in shape which is determined by SEM. Average size of the AgNPs were between 80-98, 60-95 and 34-70 nm for PzAgNPs, SaAgNPs and TaAgNPs, respectively. Further, the synthesized AgNPs were characterized by XRD, EDX, DLS and Zeta potential analysis. Moreover, the synthesized AgNPs exhibited a dose-dependent cytotoxicity against human liver and prostate cancer cell lines. The inhibitory concentration (IC50) values of HepG2, PC3 and Vero cells were found to be 70.97, 58.61, 96.41; 10.04, 42.77, 83.86; and 28.42, 41.78, 69.48 μg/ml for PzAgNPs, SaAgNPs and TaAgNPs at 48 h incubation. An induction of apoptosis was confirmed by DNA fragmentation, Hoechst, Rhodamine and AO/EtBr staining. The present results strongly suggested that the AgNPs synthesized using P. zeylanica, S. anacardium and T. arjuna extracts showed potential anticancer activity of HepG2 and PC3 cell lines.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27483851     DOI: 10.1166/jnn.2016.12336

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  6 in total

1.  Antitumor activity of silver nanoparticles in Ehrlich carcinoma-bearing mice.

Authors:  Monira M Rageh; Reem H El-Gebaly; Marwa M Afifi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-03       Impact factor: 3.000

2.  Role of Salvia officinalis Silver Nanoparticles in Attenuation Renal Damage in Rabbits Exposed to Methotrexate.

Authors:  M A Saud; N A Saud; M A Hamad; L Farhan Gar
Journal:  Arch Razi Inst       Date:  2022-02-28

3.  Glucose-Functionalized Silver Nanoparticles as a Potential New Therapy Agent Targeting Hormone-Resistant Prostate Cancer cells.

Authors:  Mariana Morais; Vera Machado; Francisca Dias; Patrícia Figueiredo; Carlos Palmeira; Gabriela Martins; Rui Fernandes; Ana Rita Malheiro; Kirsi S Mikkonen; Ana Luísa Teixeira; Rui Medeiros
Journal:  Int J Nanomedicine       Date:  2022-09-16

4.  Polyplexes of retinoic acid: an in vitro study of complex nanostructures against colorectal cancer cell line (HCT-15).

Authors:  Narayan Ture; Drashti Desai; Pravin Shende
Journal:  J Mater Sci Mater Med       Date:  2021-09-14       Impact factor: 3.896

5.  Silver Nanoparticles Stabilized by Poly (Vinyl Pyrrolidone) with Potential Anticancer Activity towards Prostate Cancer.

Authors:  Ahmed A H Abdellatif; Ahmed Abdelfattah; Abdellatif Bouazzaoui; Shaaban K Osman; Issa Saad Al-Moraya; Abdulaziz M Saleh Showail; Mansour Alsharidah; Ashraf Aboelela; Osamah Al Rugaie; Tarek M Faris; Hesham M Tawfeek
Journal:  Bioinorg Chem Appl       Date:  2022-09-30       Impact factor: 4.724

6.  A Bottom-Up Synthesis Approach to Silver Nanoparticles Induces Anti-Proliferative and Apoptotic Activities Against MCF-7, MCF-7/TAMR-1 and MCF-10A Human Breast Cell Lines.

Authors:  Nurul Izzati Zulkifli; Musthahimah Muhamad; Nur Nadhirah Mohamad Zain; Wen-Nee Tan; Noorfatimah Yahaya; Yazmin Bustami; Azlan Abdul Aziz; Nik Nur Syazni Nik Mohamed Kamal
Journal:  Molecules       Date:  2020-09-22       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.